Author:
Ishikawa Hiroyuki,Menju Toshi,Toyazaki Toshiya,Miyamoto Hideaki,Chiba Naohisa,Noguchi Misa,Tamari Shigeyuki,Miyata Ryo,Yutaka Yojiro,Tanaka Satona,Yamada Yoshito,Nakajima Daisuke,Ohsumi Akihiro,Hamaji Masatsugu,Okuno Yukiko,Date Hiroshi
Funder
Japan Agency for Medical Research and Development
Japan Society for the Promotion of Science
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference36 articles.
1. cancer-facts-and-figures-2021 https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2021/cancer-facts-and-figures-2021.pdf, (n.d.).
2. A.M. Noone, K.A. Cronin, S.F. Altekruse, N. Howlader, D.R. Lewis, V.I. Petkov, L. Penberthy, Cancer incidence and survival trends by subtype using data from the surveillance epidemiology and end results program, 1992-2013, Cancer Epidemiol. Biomarkers Prev. 26 (2017) 632–641. 10.1158/1055-9965.EPI-16-0520.
3. Epithelial mesenchymal transition in aggressive lung cancers;Mittal;Adv. Exp. Med. Biol.,2016
4. Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma;Sowa;Cancer Med.,2015
5. Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial–mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma;Neri;Lung Cancer,2019